ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
BAP31 Drives Cartilage Calcification through Disruption of Autophagosome-Lysosome Fusion in Osteoarthritis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Pathological cartilage calcification represents a pivotal pathological alteration in osteoarthritis (OA), yet its underlying mechanisms remain poorly understood. Exosomes are involved in facilitating calcification, and their biogenesis may be linked to autophagy disruption. However, whether autophagy disruption regulates exosome-mediated calcification in OA remains to be elucidated. Here, B-cell receptor-associated protein 31 (BAP31) was identified as a key mechanosensitive regulator bridging this gap. Mechanical stimulation activated BAP31 in chondrocytes. Protein docking, coimmunoprecipitation assays, and competitive pull-down assays demonstrated that activated BAP31 competes with autophagy-related 14 (ATG14) for binding to syntaxin 17 (STX17), thereby disrupting the STX17-ATG14 complex, which is essential for autophagosome‒lysosome fusion. This disruption led to the accumulation of autophagosomes, which in turn drove the release of exosomes that facilitated pathological cartilage calcification. Critically, intra-articular delivery of adeno-associated virus-mediated BAP31 shRNA restored autophagosome‒lysosome fusion, suppressed exosome release, and attenuated cartilage calcification and degeneration in a rat OA model. Collectively, these findings identify BAP31 as a mechanical stress-responsive switch that couples impaired autophagy to exosome-mediated calcification, highlighting its potential as a therapeutic target for OA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.